education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Lanadexon
Lanadexon
dexamethasone
Manufacturer:
Landson
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
Dexamethasone
Indications/Uses
Inflammation, rheumatism & allergy.
Dosage/Direction for Use
1-3 caplets daily.
Administration
Should be taken with food.
Contraindications
Peptic ulcer; osteoporosis, acute infections; live vaccines. Lactation.
Special Precautions
CHF, HTN; DM, infectious disease; chronic renal failure, uremia. Elderly, childn. Pregnancy.
Adverse Reactions
Fluid & electrolyte retention, increased susceptibility to infections; growth retardation; Cushingoid states; amenorrhoea; hyperhidrosis, mental disturbances, intracranial HTN; acute pancreatitis; aseptic osteonecrosis.
View
ADR Reporting Link
Drug Interactions
Barbiturates, phenytoin, rifampicin.
MIMS Class
Corticosteroid Hormones
ATC Classification
H02AB02 - dexamethasone ; Belongs to the class of glucocorticoids. Used in systemic corticosteroid preparations.
Regulatory Classification
K
Presentation/Packing
Form
Lanadexon caplet 500 mcg
Packing/Price
10 × 10's (Rp8,500/boks);1000's (Rp20,000/pak)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk